Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334853 · ClinicalTrials.gov registry record
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 97
- Enrollment target
NCT01334853 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 97 participants.
The verdict
NCT01334853 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
The rationale for conducting this study is to explore potential clinical and peripheral biomarkers in subjects requiring daily medium to high dose inhaled corticosteroids for persistent asthma
Interventions
- OTHER No drug will be used
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01334853
The ClinicalTrials.gov registry entry for NCT01334853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No drug will be used is the first listed.
NCT01334853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01334853 about?
NCT01334853 is a clinical study titled "A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma". The rationale for conducting this study is to explore potential clinical and peripheral biomarkers in subjects requiring daily medium to high dose inhaled corticosteroids for persistent asthma
What is the current status of trial NCT01334853?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2011-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01334853?
The interventions under investigation include: No drug will be used (OTHER).
Who is sponsoring clinical trial NCT01334853?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.